T1	p 107 145	vomiting after breast cancer surgery :
T2	p 218 237	Japanese patients .
T3	p 508 527	) experience PONV .
T4	p 654 684	women who undergo mastectomy .
T5	p 906 925	Japanese patients .
T6	p 1011 1025	Japanese women
T7	p 1691 1793	total of 100 women ( mean [ SD ] age , 52 [ 7 ] years ; height , 154 [ 6 ] cm ; weight , 54 [ 7 ] kg )
T8	p 1834 1863	group comprised 25 patients .
T9	p 2753 2795	Japanese women who underwent breast cancer
T10	i 20 41	propofol , droperidol
T11	i 48 62	metoclopramide
T12	i 190 208	placebo-controlled
T13	i 312 322	anesthesia
T14	i 556 564	propofol
T15	i 624 631	placebo
T16	i 774 782	propofol
T17	i 792 846	conventional antiemetics droperidol and metoclopramide
T18	i 984 1002	placebo-controlled
T19	i 1070 1309	IV administration of propofol 0.5 mg/kg , droperidol 20 microg/kg , metoclopramide 0.2 mg/kg , or placebo ( isotonic saline ) immediately after skin suture . A standard general anesthetic technique , including sevoflurane and air in oxygen
T20	i 2105 2115	droperidol
T21	i 2146 2160	metoclopramide
T22	i 2188 2195	placebo
T23	i 2325 2335	droperidol
T24	i 2342 2350	propofol
T25	i 2355 2365	droperidol
T26	i 2441 2455	metoclopramide
T27	i 2643 2651	propofol
T28	i 2666 2676	droperidol
T29	i 2873 2883	droperidol
T30	i 2898 2936	metoclopramide 0.2 mg/kg and placebo .
T31	o 82 115	postoperative nausea and vomiting
T32	o 1549 1574	extrapyramidal symptoms .
T33	o 1942 1999	patient demographics , surgery type , or awakening time .
T34	o 2019 2023	PONV
T35	o 2240 2258	prevalence of PONV
T36	o 2422 2426	PONV
T37	o 2501 2524	Extrapyramidal symptoms
T38	o 2597 2601	PONV
T39	o 2825 2829	PONV